RT @mksarkar100: Our lab just published an article in Science Translational Medicine (@ScienceTM) which investigates the mechanism of kera…
IFN-γ enhances cell-mediated cytotoxicity against keratinocytes via JAK2/STAT1 in lichen planus. https://t.co/Tnsgyfy5iA https://t.co/VggnGUZWiy
@DrStevenTChen Hope papers like this https://t.co/2g4vGprJNf will lead to better treatment, JAKi topical or systemic have big potential for this disease. One of my very senior attendings always says LP patients rub and AD patients itch, wonder if others ha
Novel insights into a mysterious #disease, lichen planus. https://t.co/LrtTx2wZUf #dermatology #autoimmunedisease #immune #immunesystem #cure #Skin
RT @CorySimpsonMD: Amazing research from the Gudjonsson Lab opening new treatment avenues for lichen planus. Another career launched by the…
RT @mksarkar100: Our lab just published an article in Science Translational Medicine (@ScienceTM) which investigates the mechanism of kera…
RT @CorySimpsonMD: Amazing research from the Gudjonsson Lab opening new treatment avenues for lichen planus. Another career launched by the…
RT @Kahlenberglab: It sure is fun to collaborate with such amazing scientists! Check out the latest from the Gudjonsson lab! IFN-γ enhance…
Amazing research from the Gudjonsson Lab opening new treatment avenues for lichen planus. Another career launched by the Dermatology Foundation and NPF @DermatologyNews @DermTimesNow @SocInvestDerm @UMichiganNews @AADmember @NPF @AADskin @MishaRosenbach ht
RT @gmicevic: Tofacitinib for lichen planus, anyone ? https://t.co/epbWfAmlnF
Tofacitinib for lichen planus, anyone ? https://t.co/epbWfAmlnF
RT @Kahlenberglab: It sure is fun to collaborate with such amazing scientists! Check out the latest from the Gudjonsson lab! IFN-γ enhance…
RT @Kahlenberglab: It sure is fun to collaborate with such amazing scientists! Check out the latest from the Gudjonsson lab! IFN-γ enhance…
RT @DermalCell: IFN-γ enhances cell-mediated cytotoxicity against keratinocytes via JAK2/STAT1 in lichen planus. @UMich @ScienceTM https://…
IFN-γ enhances cell-mediated cytotoxicity against keratinocytes via JAK2/STAT1 in lichen planus. @UMich @ScienceTM https://t.co/Xskgf1B8VW
IFN-γ enhances cell-mediated cytotoxicity against keratinocytes via JAK2/STAT1 in lichen planus. https://t.co/3HLBaSXh70
baricitinib may become a promising biological treatment for LP 扁平苔癬(LP)のJAK阻害剤baricitinib治療は有望 https://t.co/5IKh9uu50j
#Skin #immunology is such an exciting area right now! @ScienceTM #jak #jak2
RT @Kahlenberglab: It sure is fun to collaborate with such amazing scientists! Check out the latest from the Gudjonsson lab! IFN-γ enhance…
RT @Kahlenberglab: It sure is fun to collaborate with such amazing scientists! Check out the latest from the Gudjonsson lab! IFN-γ enhance…
RT @Kahlenberglab: It sure is fun to collaborate with such amazing scientists! Check out the latest from the Gudjonsson lab! IFN-γ enhance…
It sure is fun to collaborate with such amazing scientists! Check out the latest from the Gudjonsson lab! IFN-γ enhances cell-mediated cytotoxicity against keratinocytes via JAK2/STAT1 in lichen planus https://t.co/lDVxYosS6q
RT @LabWaggoner: IFN-γ enhances keratinocyte death in lichen planus. Thoughts @AsthmaResCincy, @GKhuranaHershey, @DOchayon? https://t.co/h9…
IFN-γ enhances keratinocyte death in lichen planus. Thoughts @AsthmaResCincy, @GKhuranaHershey, @DOchayon? https://t.co/h9TtSSQjT8
RT @mksarkar100: Our lab just published an article in Science Translational Medicine (@ScienceTM) which investigates the mechanism of kera…
RT @mksarkar100: Our lab just published an article in Science Translational Medicine (@ScienceTM) which investigates the mechanism of kera…
RT @mksarkar100: Our lab just published an article in Science Translational Medicine (@ScienceTM) which investigates the mechanism of kera…
Our lab just published an article in Science Translational Medicine (@ScienceTM) which investigates the mechanism of keratinocyte death in lichen planus, an inflammatory disease characterized by lesions on the skin or mouth. https://t.co/Ji4FOpoElb